فهرست مطالب محمد طبرستانی

Hydatidosis is one of the most prevalent zoonotic diseases around the world that is endemic in Iran too. In rural areas, there is a higher risk of infection. To the best of our knowledge, no study was done on seroprevalence of hydatidosis in Qaemshahr, north of Iran, so, we aimed to investigate this condition and its risk factors in patients attending Qaemshahr rural health centers using ELISA method.

A total of 403 serum samples were collected. The participants completed a researcher-made questionnaire. Then, anti-echinococcus granulosus antibody was analyzed using ELISA method. Data analysis was done applying logistic regression in SPSS V24.

Eleven cases (2.73%) were found positive for anti-echinococcus granulosus antibody. There were no significant differences between seropositivity and gender, consumption of raw vegetable, non-chlorinated water and contact with dog and soil (P>0.05), but significant relationships were seen between anti-echinococcus granulosus antibody and abdominal pain and consumption of wild vegetables (P< 0.05).

In this study, the prevalence of hydatidosis was similar to other parts of Iran. Further studies considering lifestyle and other variables are suggested in all areas of Mazandaran province with similar climate to Qaemshahr.

Scleromyxedema (SM), a rare progressive cutaneous mucinosis with a systemic involvement, presents with progressive dermal mucin depositions, causing skin thickening. In addition to the skin involvement and paraproteinemia, patients with SM also have other complications. The systems which are commonly involved include the gastrointestinal, musculoskeletal, pulmonary, cardiovascular, renal, and central nervous systems. Scleromyxedema is difficult to treat. We present a patient with severe Scleromyxedema with cutaneous, gastrointestinal, musculoskeletal and renal manifestations. Following failed therapeutic attempts, she responded to treatment with intravenous gammaglobulin (IVIG), prednisolone, and azathioprine. As a result of treatment with IVIG, the patient showed dramatic improvement in her clinical symptoms and remained in remission throughout the course of combination IVIG infusions and prednisolone. We concluded that an IVIG-prednisolone combination may be an effective novel treatment of Scleromyxedema.